What do you think?
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
What do you think?
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
#learnbiotechinvesting #investing #BiotechPrometheus
#learnbiotechinvesting #investing #BiotechPrometheus
There are many events, some nuanced, that happen after Phase 3 results but before approval that can impact outcomes.
Keep these in mind as an #investor
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
There are many events, some nuanced, that happen after Phase 3 results but before approval that can impact outcomes.
Keep these in mind as an #investor
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
#Investors should understand how good these biomarker tests are
You'll often see % sensitivity and % specificity quoted
Here's what they mean
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
#Investors should understand how good these biomarker tests are
You'll often see % sensitivity and % specificity quoted
Here's what they mean
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
A serious investor MUST read these!
They are the ultimate arbiter for approval in the US
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
A serious investor MUST read these!
They are the ultimate arbiter for approval in the US
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Hard to know without raw data but be prepared to ask & investigate where possible!
#learnbiotechinvesting #biotechinvesting #BiotechPrometheus
Hard to know without raw data but be prepared to ask & investigate where possible!
#learnbiotechinvesting #biotechinvesting #BiotechPrometheus
It takes a disease prevalence (or incidence) and turns it into annual revenue. This is what is plugged into other models
Here's an example:
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
It takes a disease prevalence (or incidence) and turns it into annual revenue. This is what is plugged into other models
Here's an example:
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
That will impact your analysis
This is from 2013. If there's more recent data, please cite the source below
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
That will impact your analysis
This is from 2013. If there's more recent data, please cite the source below
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
First-in-class will retain larger share if later entrants are not differentiated while a differentiated drug will gain outsized share even if a later entrant
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
First-in-class will retain larger share if later entrants are not differentiated while a differentiated drug will gain outsized share even if a later entrant
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
From 2011-2020, all blockbuster were profitable but no low selling drugs were
No immunology blockbusters in the time frame but there are now
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
From 2011-2020, all blockbuster were profitable but no low selling drugs were
No immunology blockbusters in the time frame but there are now
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
This is a drastic simplification but useful to know
Be aware of the perverse incentives #PBM
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
This is a drastic simplification but useful to know
Be aware of the perverse incentives #PBM
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
A "positive" result sometimes isn't enough if it doesn't significantly change the treatment landscape. But this can be subjective
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
A "positive" result sometimes isn't enough if it doesn't significantly change the treatment landscape. But this can be subjective
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Also keep an eye on the competition
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Also keep an eye on the competition
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Usually applied to multiple drugs in the same class it can hamper revenue potential if alternatives exist
#learnbiotechinvesting #BiotechPrometheus
Usually applied to multiple drugs in the same class it can hamper revenue potential if alternatives exist
#learnbiotechinvesting #BiotechPrometheus
Here's what the CRs/PRs/SDs mean at a high level
These are assessed on scans
I'm using RECIST v1.1 definitions
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Here's what the CRs/PRs/SDs mean at a high level
These are assessed on scans
I'm using RECIST v1.1 definitions
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Investors must embrace these facets of biotech if they want to be successful
Note that assumptions around both may differ
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Investors must embrace these facets of biotech if they want to be successful
Note that assumptions around both may differ
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Read the SEC filings! They exist to help #investors! And they are freely available, often on the company website
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Read the SEC filings! They exist to help #investors! And they are freely available, often on the company website
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Though these deals are few & far between, here are some examples:
Who will be next?
#learnbiotechinvesting #investing #BiotechPrometheus
Though these deals are few & far between, here are some examples:
Who will be next?
#learnbiotechinvesting #investing #BiotechPrometheus
Accelerated approval and Breakthrough status save a statistically significant amount of time. But Fast track does not
Investors should keep this in mind
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Accelerated approval and Breakthrough status save a statistically significant amount of time. But Fast track does not
Investors should keep this in mind
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
You won't have time to thoughtfully analyze the data when it hits
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
You won't have time to thoughtfully analyze the data when it hits
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Though it too has drawbacks
#DCF #PoS #learnbiotechinvesting #investing #BiotechPrometheus
Though it too has drawbacks
#DCF #PoS #learnbiotechinvesting #investing #BiotechPrometheus
It covers #mPFS, 12 & 24-month survival, #HazardRatio, #atRisk.
These metrics give different views of a drug.
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
It covers #mPFS, 12 & 24-month survival, #HazardRatio, #atRisk.
These metrics give different views of a drug.
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Look for: getting to right tissue, target engagement, proof of mechanism, and proof of concept
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
Look for: getting to right tissue, target engagement, proof of mechanism, and proof of concept
#learnbiotechinvesting #biotech #investing #BiotechPrometheus
It tries to factor development risk into revenue and cost assumptions.
Here is a table of PoS values:
#learnbiotechinvesting #investing #BiotechPrometheus
It tries to factor development risk into revenue and cost assumptions.
Here is a table of PoS values:
#learnbiotechinvesting #investing #BiotechPrometheus
At each step investors should ask themselves if the company is developing things in a way that will satisfy the FDA
Until a drug is approved the FDA is the most important decision maker
#BiotechPrometheus
At each step investors should ask themselves if the company is developing things in a way that will satisfy the FDA
Until a drug is approved the FDA is the most important decision maker
#BiotechPrometheus